Dr. Ritu Nayak Zacharias, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6777 W Maple Rd Fl 3, Henry Ford West Bloomfield Hospital, West Bloomfield, MI 48322 Phone: 248-325-1550 |
Dr. Glenn Krieger, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6450 Farmington Rd, Suite 105, West Bloomfield, MI 48322 Phone: 248-661-0100 Fax: 248-661-5385 |
Dr. Shelley A Nepa, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2300 Haggerty Rd Ste 2130, West Bloomfield, MI 48323 Phone: 248-669-2040 Fax: 248-669-2046 |
Rachel Verstraete, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6777 W Maple Rd, West Bloomfield, MI 48322 Phone: 248-325-0578 |
Dr. Nadine S Jennings, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2300 Haggerty Rd Ste 2150a, West Bloomfield, MI 48323 Phone: 248-926-6610 Fax: 248-926-6611 |
News Archive
Soybean oil accounts for more than 90 percent of all the seed oil production in the United States. Genetically modified (GM) soybean oil, made from seeds of GM soybean plants, was recently introduced into the food supply on the premise that it is healthier than conventional soybean oil.
People living with fatigue, abdominal discomfort and bloody diarrhea caused by the chronic inflammation of ulcerative colitis may no longer need to undergo frequent and uncomfortable endoscopies, a new study shows.
A new study of fremanezumab, an immunotherapy that counteracts one of the molecules released during migraine, was found successful in reducing the number of days that chronic migraine sufferers experienced headaches.
IBM today announced a Research collaboratory in Melbourne, Australia, where scientists from the Victorian Life Sciences Computational Initiative at the University of Melbourne and the IBM Research Computational Biology Center will use high performance computing – including IBM's Blue Gene supercomputer – to study human disease.
Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings appear online today in the journal Cancer Research.
› Verified 7 days ago